Stocks Ride Roller Coaster Ahead of Fed, and Will Tesla’s Pain Lead to Gains for Legacy Automakers? 12/13/22
CNBC's "Fast Money"
00:00
The Future of COVID Vaccines
Timothy Stanley: Merck is still worth looking at. He says the target adjustable market is much larger now. The traders are fasting the seat belts for this trade next. Plus, auto opportunity, Tesla troubles could be opening door for other automakers.
Play episode from 24:03
Transcript
